Clinical trial

Evaluation of Three Continuation Therapies After ECT Concerning Efficacy and…

NCT00437385 · Charite University, Berlin, Germany, Other · Completed

Key facts

NCT number NCT00437385
Title Evaluation of Three Continuation Therapies After ECT Concerning Efficacy and Cognition in Severly Depressed Patients
Official title Phase 1 Study: Evaluation of Three Continuation Therapies After Acute Electroconvusive Therapy (ECT) Concerning Efficacy and Cognition in Severly Depressed Patients
Acronym EffECT
Lead sponsor Charite University, Berlin, Germany, Other
Collaborators German Research Foundation
Status Completed
Phase Phase 1
Study type Interventional
Conditions Depression, Major Depression
Intervention type Behavioral, Drug, Procedure
Interventions TCAs, SSRIs, NARIs, SNRIs, Lithium, Electroconvulsive therapy, Cognitive behavioral group therapy
Enrollment 90
Start date Mar 1, 2005
Primary completion Mar 1, 2010
Completion Mar 1, 2011
First posted Feb 21, 2007
Last update posted Nov 10, 2011
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies